NCT02463071 - AZD0585 Phase III Long-term Study in Japan | Biotech Hunter

Enrollment

383

Participants

Timeline

Start Date

June 10, 2015

Primary Completion Date

March 11, 2017

Study Completion Date

March 11, 2017

Conditions

Hypertriglyceridemia

Interventions

DRUG

AZD0585

1g soft capsule

DRUG

AZD0585 placebo

1g soft capsule

Trial Locations (26)

735-0021

Research Site, Aki-gun

261-0004

Research Site, Chiba

182-0006

Research Site, Chofu-shi

812-0027

Research Site, Fukuoka

819-8551

Research Site, Fukuoka

721-0927

Research Site, Fukuyama-shi

273-0046

Research Site, Funabashi-shi

500-8717

Research Site, Gifu

664-0846

Research Site, Itami-shi

921-8035

Research Site, Kanazawa

216-0006

Research Site, Kawasaki-shi

306-0232

Research Site, Koga-shi

923-0861

Research Site, Komatsu-shi

457-0046

Research Site, Nagoya

900-0032

Research Site, Naha

950-1104

Research Site, Niigata

144-0034

Research Site, Ōta-ku

981-0923

Research Site, Sendai

983-0039

Research Site, Sendai

983-0835

Research Site, Sendai

141-6003

Research Site, Shinagawa-ku

160-0017

Research Site, Shinjuku-ku

760-0018

Research Site, Takamatsu

760-0076

Research Site, Takamatsu

560-0082

Research Site, Toyonaka-shi

901-2132

Research Site, Urasoe-shi